- Home
- LEGN vs JBTM Comparison
LEGN vs JBTM Comparison
Compare LEGN & JBTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LEGN | JBTM |
|---|---|---|
| Founded | 2014 | 1994 |
| Country | United States | United States |
| Employees | N/A | 11500 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.8B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | LEGN | JBTM |
|---|---|---|
| Price | $25.67 | $132.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | $61.33 | ★ $180.00 |
| AVG Volume (30 Days) | ★ 2.7M | 467.0K |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.34% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $42.68 | $8.10 |
| Revenue Next Year | $30.52 | $4.68 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.24 | $111.07 |
| 52 Week High | $45.30 | $170.19 |
Technical Indicators
Market Signals| Indicator | LEGN | JBTM |
|---|---|---|
| Relative Strength Index (RSI) | 58.13 | 52.28 |
| Support Level | $21.27 | $122.13 |
| Resistance Level | $26.72 | $137.17 |
| Average True Range (ATR) | 1.79 | 5.63 |
| MACD | 0.20 | 1.65 |
| Stochastic Oscillator | 40.82 | 66.83 |
Price Performance
Historical ComparisonAbout LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About JBTM JBT Marel Corporation
JBT Marel Corp operates through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions. The Protein Solutions segment includes businesses that provide solutions for the initial stage processing and harvesting of animal proteins, mainly focusing on poultry, pork, fish, and beef. The Prepared Food and Beverage Solutions segment includes businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready-to-eat or drink products. This segment will also include capabilities for pet food, dairy, bakery, pharmaceutical, nutraceutical, and warehouse automation end markets. The majority of its revenue is generated from the Prepared Food and Beverage Solutions segment.